Compare AbCellera Biologics Inc (ABCL) vs Prudential PLC (PUK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Prudential PLC — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while Prudential PLC trades at $27.79 (market cap $34.02B). The key difference: Prudential PLC is far larger — about 11.4× AbCellera Biologics Inc's market cap, and Prudential PLC pays a 1.94% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | PUK | |
|---|---|---|
Market Cap | $2.99B | $34.02B |
Sector | Health | Financials |
52-Week High | $9.76 | $33.61 |
52-Week Low | $2.78 | $24.98 |
Enterprise Value | $2.58B | $35.46B |
Dividend Yield | — | 1.94% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Prudential PLC
Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these.
Read more on PUK →
